{"database": "lobbying", "table": "lobbying_activities", "rows": [[2515270, "78dd0264-dd86-4446-a162-cd6b6b13b9e4", "Q3", "GENENTECH, INC", 15920, "GENENTECH INC", 2020, "third_quarter", "PHA", "S.2543: Prescription Drug Pricing Reduction Act of 2019.\nH.R.3: Lower Drug Costs Now Act of 2019.\nH.R.19: Lower Costs, More Cures Act of 2019.\nS.551, REFUND Act of 2019\nHR 4710, 340B Pause Act and other issues relating to the 340B Drug Discount Program\n\n- Drug pricing issues\n- Prescription Drug User Fee Act reauthorization\n- Issues related to prescription drug value", "Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", null, 2710000, 0, 0, "2020-10-19T10:22:12.217000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2515270"], "units": {}, "query_ms": 0.3579980693757534, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}